Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27073157 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ngoc B Vuong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College, Nashville, TN 37208, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Drug Resistance, Neoplasm, Glycogen Synthase Kinase 3 beta, Ribosomal Protein S6 Kinases, 90-kDa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) tumors are typically heterogeneous, predominantly epithelial tissues with discrete patches of mesenchymal-like TNBC cells that differ in their invasiveness, proliferation potential and response to treatment. However, the impact of mesenchymal-like and epithelial TNBC cells on the persistence of chemotherapy-resistant disease remains poorly understood. Mesenchymal-like and epithelial TNBC cell types were detected by multiplex fluorescent immunohistochemistry using antibodies against vimentin, Ki67, and Annexin A6 (AnxA6). Chemotherapy drug-resistant mesenchymal-like and epithelial TNBC cell populations were established by pulse exposure and stepwise dose escalation and validated by 3D cultures and unbiased antibody arrays. Analysis of the response of TNBC tumors treated with six common chemotherapy regimens resulted in 36% complete response and 64% partial response with residual tumor sizes ranging from 0.5 to 37.0 mm. Treatment of TNBC cells with chemotherapy agents led to distinct resistance signatures including downregulation of survivin and upregulation of M-CSF and CXCL8/IL-8 in the model mesenchymal-like TNBC cells, and upregulation of CCL2/MCP-1, CTSS and DKK-1 in model epithelial TNBC cells. The inhibitory phosphorylation of GSK-3β (p-S9) increased in paclitaxel-resistant epithelial cells but decreased in resistant mesenchymal-like TNBC cells. Finally, chemotherapy resistance also activated p90 ribosomal S6 kinases (RSK1/2) in both cell types, while activation of mitogen- and stress-activated kinases (MSK1/2) was only observed in chemotherapy-resistant epithelial TNBC cells. These data reveal that chemotherapy resistance of epithelial and mesenchymal-like TNBC cellular subsets led to distinct profiles of proinflammatory and immune cell chemotactic cytokines and modulated the activities of GSK-3β, p90 RSK1/2 and the related MSK1/2. Targeting these factors and/or the associated signaling pathways may help overcome chemotherapy resistance in TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College, Nashville, TN 37208, USA.
- Department of Pathology, School of Medicine, Meharry Medical College, Nashville, TN 37208, USA.
- Department of Biochemistry Cancer Biology, Neuroscience and Pharmacology, School of Medicine, Meharry Medical College, Nashville, TN 37208, USA.
ORCID-Profile: Samuel E Adunyah, Amos M Sakwe
Förderung
- American Heart Association
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Heart Lung and Blood Institute
- NCI NIH HHS
- NIMHD NIH HHS
- American Cancer Society
- National Institutes of Health
Zitieren
APA
Vuong, N. B., Korolkova, O. Y., Izban, M. G., Sakwe, N. I., McIntosh, A. R., Ball, D. D., Black, P. J., Edwards, A. D., Ballard, B. R., Adunyah, S. E., & Sakwe, A. M. (2026). Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27073157
Vancouver
Vuong NB, Korolkova OY, Izban MG, Sakwe NI, McIntosh AR, Ball DD, et al. Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27073157
BibTeX
@article{Vuong2026,
author = {Vuong, Ngoc B and Korolkova, Olga Y and Izban, Michael G and Sakwe, Nobelle I and McIntosh, Antonisha R and Ball, Destiny D and Black, Perrin J and Edwards, Alayjha D and Ballard, Billy R and Adunyah, Samuel E and Sakwe, Amos M},
title = {Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27073157}
}
EUVIMED